10.85
+0.15
+(1.40%)
At close: 4:10:23 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
37,053.88
37,053.88
36,912.06
39,872.28
19,262.06
Investing Cash Flow
-29,033.93
-29,033.93
-1,027.53
-434.44
-854.33
Financing Cash Flow
-3,571.81
-3,571.81
-2,240.13
-1,503.76
-1,479.95
End Cash Position
35,200.75
35,200.75
156,813.54
121,509.28
82,690.98
Income Tax Paid Supplemental Data
15,648.11
15,648.11
7,744.92
--
--
Capital Expenditure
-5,576.22
-5,576.22
-1,027.53
-434.44
-854.33
Issuance of Capital Stock
4,155.01
4,155.01
--
--
--
Repurchase of Capital Stock
-4,909.25
-4,909.25
--
--
--
Free Cash Flow
31,477.67
31,477.67
35,884.53
39,437.84
18,407.74
6/30/2021 - 2/11/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AGN.AX Argenica Therapeutics Limited
0.6800
0.00%
RAC.AX Race Oncology Limited
0.9250
-2.63%
NEU.AX Neuren Pharmaceuticals Limited
10.53
+3.54%
EZZ.AX EZZ Life Science Holdings Limited
1.5800
0.00%
CU6.AX Clarity Pharmaceuticals Ltd
1.9000
+13.10%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
SPAGO.ST Spago Nanomedical AB (publ)
0.2170
-0.46%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
0.00%